---
title: "Sanofi MenQuadfi wins EU approval for use in infants from six weeks"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295089984.md"
description: "The European Commission has approved Sanofi's MenQuadfi meningococcal vaccine for infants as young as six weeks old, expanding its previous indication from 12 months. This approval targets invasive disease caused by serogroups A, C, W, and Y, following a positive CHMP opinion in June 2026."
datetime: "2026-08-06T10:24:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295089984.md)
  - [en](https://longbridge.com/en/news/295089984.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295089984.md)
generator: "portal-rs"
---

# Sanofi MenQuadfi wins EU approval for use in infants from six weeks

-   The European Commission extended the EU label for Sanofi’s MenQuadfi meningococcal vaccine to include infants from six weeks of age. \* MenQuadfi was previously cleared for use from 12 months and older. \* The broader indication targets invasive meningococcal disease caused by serogroups A, C, W, and Y. \* The decision follows a positive CHMP opinion issued on June 25, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanofi SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-336497), on August 06, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SNY.US](https://longbridge.com/en/quote/SNY.US.md)
- [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md)

## Related News & Research

- [Sino Biopharma rebrands global operations under SBP Group identity](https://longbridge.com/en/news/296347598.md)
- [11:55 ETSino Biopharmaceutical Limited stellt neue globale Marke SBP Group vor, um die internationale Expansion zu beschleunigen](https://longbridge.com/en/news/296378456.md)
- [What does Europe’s AI lag mean for the region?](https://longbridge.com/en/news/296510589.md)
- [Sanofi says Nexviazyme meets endpoints in phase 3 infantile-onset Pompe study](https://longbridge.com/en/news/291226762.md)
- [Abercrombie expands NFL fashion partnership, adds Fanatics distribution for 2026 season](https://longbridge.com/en/news/296352423.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**